Sponsor intelligence · OTHER
Clinical trials sponsored by
Fudan University.
Real, source-linked trial activity for Fudan University: 17 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Aug 5, 2026. Source-linked, daily-refreshed.
N/A 8PHASE2 4NA 2PHASE4 1PHASE1/PHASE2 1PHASE3 1
Newest Fudan University trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 9d ago | AI-Guided TURBT for Bladder Cancer | NA | NOT_YET_RECRUITING | ↗ |
| 19d ago | Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabet | Ph 4 | RECRUITING | ↗ |
| 20d ago | Nectin-4 PET to Predict Response to Nectin-4-Targeted Therapy in Advan | N/A | ACTIVE_NOT_RECRUITING | ↗ |
| 20d ago | Real-World Study of Young Patients With Solid Tumors in China | N/A | RECRUITING | ↗ |
| 21d ago | Granzyme B-PET: Predicting Immunotherapy Efficacy in TNBC | N/A | RECRUITING | ↗ |
| 22d ago | Dietary Pattern Intervention for Neurodevelopment in Preterm Infants | NA | NOT_YET_RECRUITING | ↗ |
| 23d ago | PD-1 Inhibitors Combined With Local Therapy at Different Timings in Ol | N/A | RECRUITING | ↗ |
| 26d ago | A Multicenter, Single Arm Study to Evaluate the Preliminary Efficacy a | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 26d ago | A Clinical Risk Score to Stratify High-risk PanNETs | N/A | COMPLETED | ↗ |
| 27d ago | MRI-Driven Precision Typing and Response Prediction in Luminal Breast | N/A | ACTIVE_NOT_RECRUITING | ↗ |
| 30d ago | Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-t | Ph 1/Ph 2 | NOT_YET_RECRUITING | ↗ |
| 41d ago | An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan Wit | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 42d ago | A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib R | Ph 2 | RECRUITING | ↗ |
| 43d ago | Iparomlimab and Tovorilimab (QL1706) Combined With Bevacizumab and Che | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 43d ago | Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 48d ago | Epidemiology and Prognostic Analysis of Chinese Cancer Patients With C | N/A | RECRUITING | ↗ |
| 49d ago | A Phase II Observational Clinical Study on the Relationship Between Ce | N/A | RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Fudan University (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.